In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 4th, 2005 | 13 | Yes |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 4.29 | 3.88 | -2.56 | 1 | 3 | 0 | 42 | 434.711 | 0 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 9.04e-03 g/l | DrugBank-experimental |
PUBCHEM_PATENT_ID | EP0320691A2; EP0320691B1; US5006452; US6054257 | IBM Patent Data |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CSK21-3-E | Casein Kinase II Alpha (cluster #3 Of 3), Eukaryotic | Eukaryotes | 900 | 0.65 | Binding ≤ 10μM |
CSK2B-2-E | Casein Kinase II Beta (cluster #2 Of 3), Eukaryotic | Eukaryotes | 500 | 0.68 | Binding ≤ 10μM |
DYR1A-2-E | Dual Specificity Tyrosine-phosphorylation-regulated Kinase 1A (cluster #2 Of 3), Eukaryotic | Eukaryotes | 1000 | 0.65 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CSK21_HUMAN | P68400 | Casein Kinase II Alpha, Human | 400 | 0.69 | Binding ≤ 1μM |
CSK2B_HUMAN | P67870 | Casein Kinase II Beta, Human | 500 | 0.68 | Binding ≤ 1μM |
DYR1A_HUMAN | Q13627 | Dual-specificity Tyrosine-phosphorylation Regulated Kinase 1A, Human | 1000 | 0.65 | Binding ≤ 1μM |
CSK21_HUMAN | P68400 | Casein Kinase II Alpha, Human | 1740 | 0.62 | Binding ≤ 10μM |
CSK2B_HUMAN | P67870 | Casein Kinase II Beta, Human | 1740 | 0.62 | Binding ≤ 10μM |
DYR1A_HUMAN | Q13627 | Dual-specificity Tyrosine-phosphorylation Regulated Kinase 1A, Human | 1000 | 0.65 | Binding ≤ 10μM |
Description | Species |
---|---|
Condensation of Prometaphase Chromosomes | |
G0 and Early G1 | |
Signal transduction by L1 | |
WNT mediated activation of DVL |